Latest market news

Shiba Inu, one of the largest meme coins in the crypto space, has gone live on Solana through Sunrise, giving Solana market access to the Ethereum token's canonical form. The move brings SHIB onto the Solana network via the Sunrise integration. The listing provides Solana market participants with access to the canonical form of the Ethereum-based token.

Tesla's third-quarter deliveries beat company-compiled analyst expectations by 5.3%, though they declined 2.1% from a year earlier, a drop partly cushioned by Q3 2025's tax credit boost. Seeking Alpha analyst Oliver Rodzianko said the biggest takeaway is that traditional EV demand remains resilient as Tesla pivots toward autonomous taxi services and humanoid robotics as its dominant operating models, while energy storage deployment numbers missed expectations. Rodzianko noted that Chinese rival BYD saw its battery-electric passenger-car sales rise 30.9% year-over-year in the third quarter, underscoring fierce competition in China. Analyst Alexander Grover argued the delivery number is a distraction, since Tesla's valuation assumes unsupervised self-driving at scale, and flagged that Alphabet's Waymo is running more than 500,000 paid driverless rides a week across 15 U.S. metros with LiDAR in its stack, while Tesla still does not disclose how many of its robotaxis run without a safety monitor.

Aris Mining has completed the Environmental and Social Impact Assessment for its Soto Norte gold-copper project in Santander, Colombia, and in 2026 began formal community engagement across three municipalities ahead of submitting the ESIA and environmental license application. The company said Soto Norte lies outside the Santurbán Páramo and its buffer zone, and it aligned the ESIA and consultation process with Colombia's regulatory framework and the Escazú Agreement. The milestone follows the ANM's July 29, 2026 approval of the modified technical mine plan for Soto Norte, which confirmed regulators have reviewed the project's geology, reserves and mine design but does not replace the need for an environmental license before construction or mining can begin. Aris Mining's narrative projects $2.2 billion revenue and $688.8 million earnings by 2029, requiring 19.9% yearly revenue growth and a $404.1 million earnings increase from $284.7 million today, with a CA$41.53 fair value implying 66% upside. Some of the lowest estimate analysts had assumed about US$2.0 billion of revenue and US$797.7 million of earnings by 2029 while still citing Soto Norte's lengthy permitting and heavy ESG commitments as reasons for caution.

Costco Wholesale Corporation closed fiscal 2026 with total revenue of $276.4 billion, up 8.1% year over year, as the warehouse retailer reported net sales of $93.87 billion, up 11.2%, and net income of $2.998 billion in its September 24 earnings call. Membership remains the engine of the business, with 84.1 million paid members, including 42.3 million Executive tier members, a group that grew 9.4% and pushed that tier's share of the base to a new high, while renewal rates rose to 92.3% in the US and Canada and 89.8% worldwide. Membership fee income climbed 7.3% to $1.849 billion, and management plans 33 openings in fiscal 2027 as it works toward 30 net new warehouses a year, with digitally enabled sales topping $33 billion on growth above 20%. The quarter was not spotless, as reported gross margin slipped to 11.02% from 11.13% a year earlier and the LIFO charge jumped to $152 million from $43 million, tied to pricier memory in electronics and Middle East conflict costs for gas, motor oil, and resins, while tariff refunds added $0.15 per share and the $184 million received covers only about a third of the expected recovery. With the stock trading near historical valuation highs at a forward P/E of 40.32 and hedge fund ownership slipping to 104 funds from 107, the debate now centers on whether membership loyalty and the expansion plan can keep earnings growing into a premium that leaves little room for a stumble.

Scholastic reported a first-quarter net loss of $71.2 million, or $3.77 per share, on revenue that slipped 4% to $216.8 million, while management left its full-year targets untouched. The quarter is the quietest stretch of Scholastic's year, making up only 14% of full-year revenue last year, so the real test is the fall, where Book Fairs bookings and fair counts are both running ahead of last year and the company is reaching new school communities including Christian schools. Content catalysts are stacking up: an HBO adaptation of Harry Potter arrives this Christmas, a new Dog Man title lands in November alongside a Hunger Games film, and entertainment revenue rose 48% to $20.1 million on heavier production activity. The balance sheet improved as net debt fell to $86.8 million from $242.8 million a year earlier, largely on sale-leaseback deals completed in December 2025, and the company bought back $25.8 million of its own stock during the quarter. Still, education revenue fell $9.7 million to $30.4 million amid higher district staffing costs and the end of ESSER pandemic relief funding in March, overhead climbed $5 million to $23.3 million, and free cash use for the quarter was $110.8 million, worse than last year's $100.2 million, leaving full-year adjusted EBITDA targets of $135 million to $145 million and free cash flow of $35 million to $40 million to be built on top of a first-quarter adjusted EBITDA loss of $63.6 million.

Accenture reported fourth-quarter results on October 1 that beat its own revenue guidance, with revenue of $18.7 billion, up 7% in local currency, and bookings of $22.2 billion outrunning revenue. Every geography and both consulting and managed services grew at that same 7% pace, and managed services set a fourth-quarter record at $12.8 billion. The company ended fiscal 2026 with nearly 110,000 AI and data professionals, past its 80,000 target, while more than 400 clients began advanced AI projects during the year and bookings from its eight emerging AI and data partners more than tripled. Free cash flow reached $11.6 billion, about 1.4 times net income, and Accenture returned $11.5 billion to shareholders through $7.5 billion of buybacks and $4 billion of dividends, with at least $9.5 billion planned for fiscal 2027 and a quarterly dividend of $1.71 per share, up 5%, already declared. Fiscal 2027 guidance calls for 3% to 6% revenue growth in local currency, with 2% to 2.5% of that from acquisitions, and earnings per share guided to climb 3% to 6%, while the shares carry a forward P/E of 12.41 as of October 2.

Starknet's STRK token extended its rally Sunday, rising about 16% as a burst of speculative trading added momentum to the blockchain network's push to attract Bitcoin holders. STRK climbed from roughly $0.044 to $0.057 in the past 24 hours, after jumping about 26% Saturday, and by 12:08 p.m. ET Sunday CoinGecko showed more than $240 million in 24-hour volume and a market capitalization of about $427 million. The token has gained more than 35% in the past week and more than doubled in the past month. The rally accelerated Saturday after a crypto trader using the name Pumponomics posted a bullish STRK thesis on X at about 10:33 a.m. ET, saying he had accumulated about $740,000 of the token during the week, and on-chain data showed a wallet receiving about 17.44 million STRK from Coinbase Prime minutes before the post. Futures trading also surged, with volume rising about 213% to $187.7 million and open interest climbing about 20% to $74.2 million Saturday. The speculative activity followed an Oct. 2 announcement from Starknet that it would cover bridge fees for the first 100 Bitcoin moved onto its network through strkBTC, a Bitcoin-backed token that lets holders use their Bitcoin in applications on Starknet, with staking through Endur paying rewards in STRK at an annual percentage yield of about 3%. A further potential catalyst is approaching Monday, when Starknet v0.14.4 is scheduled for mainnet deployment Oct. 5, pending governance approval.

AZZ is drawing investor attention ahead of its scheduled October 13, 2026 earnings release, with analysts projecting earnings per share growth of 17.42% versus the prior year and a forward P/E ratio below the industry average. The company recently extended and repriced its revolving credit agreement to May 2029, lowering interest margins and fees and giving it more financial flexibility as it ramps its St. Louis area greenfield plant and pursues acquisitions. AZZ's narrative projects $1.9 billion in revenue and $215.1 million in earnings by 2029, requiring 5.2% yearly revenue growth and a $102.2 million earnings decrease from $317.3 million, with a $161.67 fair value implying 16% upside to the current price. Some analysts hold a more optimistic view, assuming revenues around US$1.9 billion and earnings near US$212.9 million before this news. Risks remain, including prolonged weather related production losses, production disruptions, and execution at newer facilities.

TC Energy Corporation has confirmed that Coastal GasLink Phase 2 will proceed following LNG Canada's expansion decision, nearly doubling capacity along the existing 670-kilometre route in British Columbia through new compressor stations and facility upgrades. Construction on the expansion is expected to start in early 2027, with service targeted for the early 2030s. The company also declared a continued quarterly dividend of C$0.8775 per share, or C$3.51 annualized. TC Energy's narrative projects CA$18.2 billion in revenue and CA$5.3 billion in earnings by 2029, with a fair value estimate of CA$98.78 implying 17% upside to the current price. Two fair value estimates from the Simply Wall St Community span from C$33.89 to C$98.78.

Vor Biopharma reported a post hoc analysis from a China-based Phase 3 trial showing that telitacicept produced deep, durable clinical responses and was generally well tolerated over 48 weeks in adults with generalized myasthenia gravis. The analysis highlighted that most patients who reached minimal symptom expression maintained it and spent much of their remaining follow-up in this state. The new data reinforce the depth and durability of response but do not materially change the key near-term catalyst, the UPSTREAM global Phase 3 topline readout in 2027, or the central risk that global data might not match prior China experience. The results sit beside Vor's completion of enrollment in the global UPSTREAM Phase 3 gMG trial in early September 2026. Vor Biopharma's narrative projects $111.0 million revenue and $19.1 million earnings by 2029, implying an earnings decrease of $608.7 million from $627.8 million today, and forecasts a $39.00 fair value, a 109% upside to its current price.

Corpay has expanded its Corpay Complete platform with several new AI agents that automate expense analysis, voice driven expense creation, virtual card issuance, and transaction coding across corporate, fleet, and vendor payments. The new tools are being rolled out to eligible Corpay Complete customers this month and are designed to centralize spend data, strengthen finance grade controls, and streamline workflows for finance teams. The rollout lands on top of earlier product updates in April and July, and comes as Corpay has raised its 2026 cash EPS guidance to $27.35 and plans to use divestiture proceeds for repurchases, alongside roughly $15b of available capital for buybacks and targeted corporate payments deals. Corpay closed at $394.60, while the most followed narrative pegs fair value at $461.00, implying 14.4% undervaluation, though on a P/E lens CPAY trades at 22.9x versus a US Diversified Financial industry average of 16.6x, a peer average of 16.9x, and a fair ratio of 16.8x. The company also faces pressure if the proposed US$100m U.S. Vehicle Payments settlement reshapes fuel card pricing or if organic growth underperforms current analyst assumptions.

Alignment Healthcare announced that its Alignment Health Plan will add Hoag, a large Orange County health system, to its network for Medicare members starting January 1, 2027. The agreement comes as Alignment Healthcare's share price sits under pressure, with the stock down 41.36% on a 30 day share price return basis and 60.73% year to date, while the 3 year total shareholder return remains positive at 8.47% and the 1 year total shareholder return has declined 52.23%. Analysts following the company see a wide gap between their narrative fair value of about $22.23 and the last close at $7.94, with 14 investors viewing Alignment Healthcare as 64% undervalued. On simple P/E math the stock screens as expensive, trading at about 40.5x earnings versus 24.3x for the wider US Healthcare industry and roughly 34.5x for peers, even though the fair ratio is estimated at 43x. The bull case rests on a technology-enabled care model, administrative automation and expansion into existing counties and new states, but it depends on stable Medicare Advantage funding and clean accounting, and any adverse regulatory or legal outcome could quickly challenge those assumptions.

Maple Leaf Foods Inc. will consolidate its U.S. plant protein production into a single Centre of Excellence in Indianapolis, winding down its Seattle and Turners Falls plants in phases through the fourth quarter of 2027. The move is part of the company's Fuel for Growth initiative, which aims to simplify its manufacturing footprint, enhance efficiency and support its plant protein brands more competitively. The consolidation update sits alongside Maple Leaf's recent first-quarter 2026 results, which showed CA$962.85 million in sales and CA$46.07 million in net income. Maple Leaf's narrative projects CA$5.6 billion in revenue and CA$467.3 million in earnings by 2028, requiring 4.2% yearly revenue growth and an earnings increase of about CA$372.7 million from CA$94.6 million today. Two fair value estimates from the Simply Wall St Community span CA$35.90 to CA$83.26, against a CA$35.90 fair value estimate that implies 45% upside to the current price.

American Airlines said eligible AAdvantage members will be able to combine cash and miles when buying tickets through its website and mobile app, a feature rolling out in the coming weeks. Members will first select flights priced in cash, then at checkout American will display combinations of cash and AAdvantage miles that can be adjusted with a slider, with the total price updating based on the mix selected. The change gives customers another way to use mileage balances without accumulating enough points to cover an entire award ticket, and American characterized it as part of a broader effort to give AAdvantage members more flexibility in how they use the program. The move comes as competition for lucrative frequent flyers intensifies: United Airlines recently launched a status-match campaign aimed directly at elite members of American and Delta Air Lines, offering qualifying American and Delta customers comparable MileagePlus status for 90 days, extendable through Jan. 31, 2028 by meeting flight and spending requirements ranging from $1,500 in eligible United spending for entry-level Premier Silver status to $7,000 for Premier 1K. American has its own status-match offers for qualifying customers of United, Delta, Southwest Airlines and JetBlue Airways. American has also been expanding AAdvantage benefits, with members reaching 15,000 Loyalty Points able to choose two eligible inflight food and beverage coupons, rewards at various levels now including subscriptions to The New York Times, Games, Cooking and The Athletic, and additional gift choices planned for customers reaching Million Miler milestones.

Goldman Sachs expects the S&P 500 to deliver another strong earnings season, with artificial intelligence investment driving an increasingly large share of corporate profit growth, according to an Oct. 2 report led by strategist Ben Snider. Consensus forecasts call for S&P 500 earnings per share to rise 27% from a year earlier in the third quarter, a slowdown from the 33% growth recorded in the second quarter after excluding accounting distortions, and Goldman expects most companies to beat consensus estimates again. The headline growth rate masks an unusually concentrated picture: information technology and energy are expected to generate nearly 80% of the index's earnings growth, AI infrastructure companies alone are expected to account for more than half of S&P 500 EPS growth, and the 10 biggest contributors are forecast to generate 68% of that growth, with Micron Technology and Nvidia together accounting for more than one-third. Micron has already reported, posting year-over-year earnings growth of 1,003% and beating consensus estimates. For the median S&P 500 company the outlook is considerably less spectacular, with consensus forecasts calling for EPS growth of 9%, down from 14% in the second quarter, revenue growth slowing to 6% from 7%, and a third-quarter net margin of 14.7% versus 15.1% in the previous quarter. The coming reports could also test whether enormous AI investments are translating into revenue, with consensus forecasts calling for hyperscaler capital spending to jump 116% from a year earlier in the third quarter, accelerating from 87% growth in the second, and Goldman expecting hyperscaler capex to grow more than 50% in 2027 and exceed the roughly $1.1 trillion currently embedded in consensus forecasts. Goldman forecasts S&P 500 EPS of $375 for 2026, up 36% from 2025, followed by $415 in 2027, with a year-end 2026 S&P 500 target of 8,000 and a 12-month target of 8,700.

Halliburton confirmed to Argentine authorities in early October 2026 that it and its subsidiaries will not work on the Malvinas Islands' Sea Lion project or conduct any hydrocarbon activities in the surrounding area, while separately signing memoranda of understanding with Eneva S.A. and WESCA to support oil and gas development opportunities in Venezuela. The two moves together reframe Halliburton's regional exposure, regulatory risk profile and future contract pipeline across Latin America, with the Venezuela agreements offsetting some perceived lost optionality around Malvinas through a different Latin American pathway for international revenue, offshore and unconventional exposure. Those agreements sit alongside recent multi-year wins in Suriname, Brazil and Cyprus, reinforcing that the key short-term catalyst remains Halliburton's ability to execute on higher-complexity international contracts at acceptable margins and with controlled start-up costs. Halliburton's narrative projects $25.1 billion in revenue and $2.7 billion in earnings by 2029, requiring 3.9% yearly revenue growth and an earnings increase of about $1.1 billion from $1.6 billion today, and yields a $43.44 fair value, a 36% upside to its current price. More optimistic analysts had already assumed revenues of about US$26.8 billion and earnings near US$3.4 billion before the Venezuela and Malvinas news, while other fair value estimates put the stock as low as $34.03.

Canadian Natural Resources and four other oil sands producers, together with the federal and Alberta governments, committed in late September 2026 via a trilateral MOU to advance the Pathways CCS project, targeting up to 16 million tonnes of CO2 capture annually by 2045, with final binding terms still pending. The conditional framework directly links potential future oil sands expansion to large-scale emissions management, which could reshape long-term cost structures, policy risk and capital allocation for Canadian Natural Resources. The company's key short-term catalyst remains operational and cash flow delivery against 2026 guidance, while the biggest current risk centers on future carbon costs and long-term policy exposure should the framework move from conditional to binding terms. Recent announcements also include substantial share buybacks alongside a CAD 0.625 quarterly dividend, highlighting a tension between returning cash today and preserving flexibility for potentially large CCS and growth commitments. The company's narrative projects CA$40.8 billion in revenue and CA$8.9 billion in earnings by 2029, with a CA$72.71 fair value estimate, while the lowest-estimate analysts assume revenues could fall to about CA$38.0 billion and earnings to CA$5.5 billion.

Strategy founder and chairman Michael Saylor published data on the company's Bitcoin strategy with the concise comment: "More orange than ever." The post, which appeared on the company formerly known as MicroStrategy, signals a potential massive new Bitcoin purchase by the firm. Saylor's terse remark accompanied the release of the company's Bitcoin strategy data, though no specific purchase amount or dollar figure was disclosed in the source material. The comment echoes Saylor's long-running practice of teasing Strategy's Bitcoin acquisitions ahead of official announcements.

Nvidia's board authorized an additional $150B for its existing share-repurchase program, bringing the remaining authorization to $235B, which the company said was the largest increase to a share-repurchase authorization in history. Micron Technology reported fiscal fourth-quarter results and guidance that topped Wall Street's expectations by a wide margin, earning an adjusted $33.42 per share as revenue soared 379.1% year-over-year to $54.23B, versus analyst expectations of $31.72 per share on $51.49B in revenue. Accenture shares rose after its Q4 beat expectations and it forecast upbeat fiscal 2027 revenue growth, reporting GAAP earnings of $3.29 per share, revenue up 6.3% year over year to $18.7B, and new bookings of $22.2B. MongoDB shares fell after CEO Chirantan Desai stepped down effective immediately to become the newly created Chief Enterprise Platform Officer at Meta, with the board appointing Dev Ittycheria as interim president and CEO. Summit Therapeutics shares surged after AstraZeneca announced a $2B equity investment in the U.S. biotech and a clinical collaboration to develop new cancer treatments, purchasing convertible preferred shares at a conversion price equivalent to $18.36 per common share, a 10% premium to Summit's five-day volume-weighted average price. For the week, the Dow fell 1.26%, the S&P 500 lost 0.27%, and the Nasdaq Composite climbed 0.45%.

The U.S. Supreme Court opened its new term Monday with arguments in a case that could determine whether ExxonMobil and Suncor Energy can be held liable under state law for costs attributed to climate change. The dispute stems from a lawsuit filed by the city and county of Boulder, Colorado, accusing the oil producers of contributing to climate change and misleading the public about the risks of fossil fuels, and seeking compensation for infrastructure repairs, emergency management, environmental damage and public health effects. Exxon and Suncor appealed after the Colorado Supreme Court allowed the case to proceed, arguing that federal law including the Clean Air Act bars state and local governments from pursuing claims that effectively regulate greenhouse-gas emissions, a position backed by the Trump administration. The stakes extend well beyond Colorado, as nearly 60 state and local governments have filed similar lawsuits seeking billions of dollars from fossil-fuel producers, and a broad ruling for the companies could provide grounds for dismissing many of those cases. The court has a 6-3 conservative majority, though Justice Samuel Alito has recused himself, and a decision is expected by the end of June.

The U.S. Department of Energy has approved a roughly US$4.00 billion federal loan package for Vistra to upgrade three nuclear plants serving the PJM grid, as power demand climbs from data centers and other intensive users. The federal backing supports nuclear capacity upgrades and underscores Vistra's role as a reliability provider in a tightening U.S. power system. The loan sharpens the company's investment narrative around long-term contracted power, though Vistra has separately challenged PJM's Interim Resource Adequacy Service at FERC, arguing the measure could chill investment and misprice capacity for large loads. Vistra's narrative projects $26.0 billion in revenue and $4.1 billion in earnings by 2029, requiring 10.7% yearly revenue growth and a $2.1 billion earnings increase from $2.0 billion today, while some analysts assume revenues near US$33.4 billion and earnings around US$4.9 billion by 2029.

Emera has raised its quarterly dividend to CA$0.74 per share, implying an annual payout of CA$2.96, a 1% increase from the previous CA$2.93 level. The move comes after a softer stretch for the share price, with a 90 day return down 7.98% and a 30 day return down 1.88%, though the 1 year total shareholder return of 6.77% and 3 year total shareholder return of 68.08% reflect longer-term momentum. The most followed valuation narrative pegs Emera's fair value at roughly CA$74.45 per share, above the recent CA$68.42 close, framing the higher dividend as an 8% undervalued case. That view rests on heavy investment in grid modernization, renewables including a $2+ billion solar expansion in Florida, and infrastructure resilience, but faces risks from refinancing needs and exposure to cyber incidents and extreme weather. On valuation, Emera trades at 21.8x earnings, above Canadian peers at 20.9x and the wider North American utilities group at 19.8x, while the fair ratio sits higher at 29x.

Rio2 Limited launched a two-phase surface drilling and district-scale exploration program at its Condestable Copper Mine in Peru while suspending drilling at the Fenix Gold Mine in Chile, according to a September 2026 company-wide exploration update. The Condestable campaign covers 33,870 metres across two phases and is designed to better understand and potentially convert both breccia-hosted and vein-hosted copper-gold-silver mineralization based on a refined geological model. The program sits on top of the August 2026 approval of the MEIA modification for Condestable, which supports expansion to 10,000 tonnes per day and dry stack tailings. Rio2 said the Fenix suspension stemmed from adverse weather, safety concerns and contractor standby costs, leaving extreme weather as the key near-term operational risk. The company's narrative projects $691.3 million in revenue and $250.6 million in earnings by 2029, requiring 59.3% yearly revenue growth and roughly a $192 million earnings increase from $58.2 million today.

A Delaware federal judge on Monday rejected requests from Pfizer, BioNTech and Moderna to dismiss lawsuits filed by Bayer's Monsanto unit over their use of US Patent No. 7,741,118, a patent related to mRNA technology, with Judge William Bryson saying the companies failed to prove the patent was invalid or not infringed by their COVID-19 vaccines. Sanofi agreed to a deal worth up to $8B, including $1B upfront, with Regeneron to jointly develop four long-acting immunology therapies, led by the clinical-stage IL-13 monoclonal antibody REGN20423. China's Abogen Biosciences signed a licensing and option agreement with Novartis worth up to $7.8B, comprising a $575 million upfront payment and up to approximately $7.2 billion in potential milestone payments if all options on all programs are exercised, covering an exclusive worldwide license to Abogen's lead asset ABO2203. Jiangsu Hengrui Pharmaceuticals agreed to license global rights to its experimental obesity drug HRS-1596 to Novo Nordisk in a deal worth up to $2.6B, with $300M upfront and the transaction expected to close in Q4 2026. Meanwhile, the S&P 500 Health Care Sector Index slipped 2.66% for the week, with Incyte down 6.93% and Regeneron down 6.71% among the top decliners, while McKesson rose 4.11% and Cardinal Health gained 3.67%.

Harmonic Inc. introduced Recon, a Comcast co-developed network monitoring and measurement family that pairs in-network hardware, handheld tools and cloud software to give broadband operators real-time visibility into fiber performance and fault locations. In parallel, Harmonic's cOS virtualized broadband platform is enabling operators like Lightcurve to deliver multi-gigabit speeds over existing coax. The Recon announcement ties most directly to Harmonic's push around cOS SensAI, since Recon's field data feeds SensAI's intelligence layer for proactive fault detection and remediation. Harmonic's narrative projects $609.8 million revenue and $92.1 million earnings by 2029, requiring 15.3% yearly revenue growth and about an $83.6 million earnings increase from $8.5 million today, while some of the lowest estimate analysts assume revenue of about US$571,000,000 and earnings of roughly US$80,000,000 by 2029.

ASUS announced that the ASUS Googlebook 14 (CX9406CAA) is now available for purchase in the United States, priced at $1,299.00, online at the ASUS Store and Best Buy. The 14-inch ultraportable is the first-ever ASUS laptop designed for Gemini Intelligence, built on a shared Android foundation for seamless integration with Android phones. It weighs just 2.18lbs and measures 0.43 inches thin, with a CNC-machined magnesium-aluminum chassis finished in Dusk Ash and protected by Nano Ceramic Technology, tested to US military-grade MIL-STD 810H and ASUS Superior Durability standards. The laptop runs an Intel Core Ultra 5 325 processor with 16GB LPDDR5X memory and up to a 512GB PCIe 4.0 SSD, and features a 14-inch 16:10 3K OLED HDR touchscreen with up to 1000 nits peak HDR brightness and a 120Hz refresh rate, a six-speaker audio system, and a 70Wh battery rated at up to 18 hours of battery life. Every purchase includes up to $500 in additional value through a curated bundle of apps and services, most notably 12 months of Google AI Pro and 5TB of cloud storage, plus three months of YouTube Premium, Adobe Premiere Pro, Adobe Photoshop, and CapCut Pro, along with 12 months of Luminar and GeForce NOW.